Long Non-Coding RNAs in Kidney Disease

Non-coding RNA species contribute more than 90% of all transcripts and have gained increasing attention in the last decade. One of the most recent members of this group are long non-coding RNAs (lncRNAs) which are characterized by a length of more than 200 nucleotides and a lack of coding potential....

Full description

Bibliographic Details
Main Authors: Michael Ignarski, Rashidul Islam, Roman-Ulrich Müller
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:International Journal of Molecular Sciences
Subjects:
AKI
Online Access:https://www.mdpi.com/1422-0067/20/13/3276
id doaj-5173f058dd4c4970b16e4c060679525b
record_format Article
spelling doaj-5173f058dd4c4970b16e4c060679525b2020-11-25T00:12:29ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-07-012013327610.3390/ijms20133276ijms20133276Long Non-Coding RNAs in Kidney DiseaseMichael Ignarski0Rashidul Islam1Roman-Ulrich Müller2Department II of Internal Medicine and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, GermanyDepartment II of Internal Medicine and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, GermanyDepartment II of Internal Medicine and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, GermanyNon-coding RNA species contribute more than 90% of all transcripts and have gained increasing attention in the last decade. One of the most recent members of this group are long non-coding RNAs (lncRNAs) which are characterized by a length of more than 200 nucleotides and a lack of coding potential. However, in contrast to this simple definition, lncRNAs are heterogenous regarding their molecular function—including the modulation of small RNA and protein function, guidance of epigenetic modifications and a role as enhancer RNAs. Furthermore, they show a highly tissue-specific expression pattern. These aspects already point towards an important role in cellular biology and imply lncRNAs as players in development, health and disease. This view has been confirmed by numerous publications from different fields in the last years and has raised the question as to whether lncRNAs may be future therapeutic targets in human disease. Here, we provide a concise overview of the current knowledge on lncRNAs in both glomerular and tubulointerstitial kidney disease.https://www.mdpi.com/1422-0067/20/13/3276lncRNAlong non-coding RNAmiRNAkidneyglomeruluspodocyteacute kidney injuryAKIdiabetic nephropathy
collection DOAJ
language English
format Article
sources DOAJ
author Michael Ignarski
Rashidul Islam
Roman-Ulrich Müller
spellingShingle Michael Ignarski
Rashidul Islam
Roman-Ulrich Müller
Long Non-Coding RNAs in Kidney Disease
International Journal of Molecular Sciences
lncRNA
long non-coding RNA
miRNA
kidney
glomerulus
podocyte
acute kidney injury
AKI
diabetic nephropathy
author_facet Michael Ignarski
Rashidul Islam
Roman-Ulrich Müller
author_sort Michael Ignarski
title Long Non-Coding RNAs in Kidney Disease
title_short Long Non-Coding RNAs in Kidney Disease
title_full Long Non-Coding RNAs in Kidney Disease
title_fullStr Long Non-Coding RNAs in Kidney Disease
title_full_unstemmed Long Non-Coding RNAs in Kidney Disease
title_sort long non-coding rnas in kidney disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-07-01
description Non-coding RNA species contribute more than 90% of all transcripts and have gained increasing attention in the last decade. One of the most recent members of this group are long non-coding RNAs (lncRNAs) which are characterized by a length of more than 200 nucleotides and a lack of coding potential. However, in contrast to this simple definition, lncRNAs are heterogenous regarding their molecular function—including the modulation of small RNA and protein function, guidance of epigenetic modifications and a role as enhancer RNAs. Furthermore, they show a highly tissue-specific expression pattern. These aspects already point towards an important role in cellular biology and imply lncRNAs as players in development, health and disease. This view has been confirmed by numerous publications from different fields in the last years and has raised the question as to whether lncRNAs may be future therapeutic targets in human disease. Here, we provide a concise overview of the current knowledge on lncRNAs in both glomerular and tubulointerstitial kidney disease.
topic lncRNA
long non-coding RNA
miRNA
kidney
glomerulus
podocyte
acute kidney injury
AKI
diabetic nephropathy
url https://www.mdpi.com/1422-0067/20/13/3276
work_keys_str_mv AT michaelignarski longnoncodingrnasinkidneydisease
AT rashidulislam longnoncodingrnasinkidneydisease
AT romanulrichmuller longnoncodingrnasinkidneydisease
_version_ 1725399431264600064